Thiazolidin-4-one derivatives
USRE45174E1 · kind E1 · reissue
13Cited by
16References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 17, 2013 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | Sep 17, 2033 |
Classification
- Technology area (CPC —)General
Abstract
The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.